Adverse Drug Reactions Viewpoints, and Reporting Status in Selected Ten Selected Developing Countries: A Brief Commentary

Abstract

The World Health Organisation defines in 1972 an Adverse Drug Reactions (ADRs) as a response to a drug which is noxious and unintended, and which occurs at doses normally used in humans for the prophylaxis, diagnosis, or therapy of disease, or for the modification of physiological function. Edwards and Aronson in 2000 recommend the subsequent definition an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product, which predicts hazard from future administration and warrants prevention or specific treatment, or alteration of the dosage regimen, or withdrawal of the product. Very restricted number (500-3000) of people or patient with cautiously, judiciously, and carefully chosen during medicine development stage for testing efficacy and safety of every medicine. There are no pharmacological agents or medicines that are effective to cure or prevent or control any disease is free of adverse effects. The thalidomide tragedy becomes visible in the late 1950s and early 1960s highlighted the inevitability generate the necessity and idea of a national and international program for post-marketing surveillance schemes to monitor the safety of medicines. The countries selected from Asia and conveniently. The articles were selected on basis of browsing in google and google scholar. This review has identified that these developing countries have achieved somewhat improvement but long way to go attain a high standard like of developed countries. Almost all studies reported that diverse educational interventions among varied health care professionals were the sole remedy for reporting ADRs.